CXCL13 and Miyoshi myopathy: Finally, immunohistochemical analysis of BM biopsies from MM pts (n = 10), plasmacytoma samples (n = 10) and normal BM samples (n = 2) demonstrated the expression of CXCL13 in malignant plasma cells.